Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

Press releases published on July 24, 2026

8 hours ago

Case Management Organizations Partner Again to Recognize Case Managers

Indeterminate GlobeNewswire

8 hours ago

Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction

Indeterminate GlobeNewswire

8 hours ago

hear.com Honored as Gold Stevie® Award Winner in 2026 Stevie Awards for Technology Excellence

Indeterminate GlobeNewswire

8 hours ago

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

Indeterminate GlobeNewswire

8 hours ago

Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study

Indeterminate GlobeNewswire

8 hours ago

Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention

Indeterminate GlobeNewswire

9 hours ago

Amwell® to report second quarter 2026 operating results

Indeterminate GlobeNewswire

9 hours ago

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

Indeterminate GlobeNewswire

9 hours ago

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Indeterminate GlobeNewswire

9 hours ago

Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make

Indeterminate GlobeNewswire

9 hours ago

BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe

Indeterminate GlobeNewswire

9 hours ago

Dyadic Announces Continued Listing on the Nasdaq Capital Market

Indeterminate GlobeNewswire

9 hours ago

Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union

Indeterminate GlobeNewswire

10 hours ago

Radiopharm Theranostics Announces Concurrent US$4.1 Million Registered Direct Offering and Up To Additional A$12.7 (US$8.9) Million Australian Placement and Share Purchase Plan

Indeterminate GlobeNewswire

10 hours ago

Treace to Report Second Quarter 2026 Financial Results on August 7, 2026

Indeterminate GlobeNewswire

10 hours ago

Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference

Indeterminate GlobeNewswire

10 hours ago

Asimov Joins the Genesis Mission, Using Boston University's NSF-Backed Cloud Lab to Power Lab-in-the-Loop AI Models

Indeterminate GlobeNewswire

10 hours ago

ANI Pharmaceuticals to Discuss Second Quarter 2026 Financial Results on August 7, 2026 at 8:00 a.m. ET

Indeterminate GlobeNewswire

10 hours ago

MannKind Announces $50 Million Private Placement

Indeterminate GlobeNewswire

10 hours ago

MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease

Indeterminate GlobeNewswire